SENSAR 3-Piece Monofocal IOL, SENSAR 1-piece IOL, TECNIS Multi-focal 1-pc, TECNIS 1-PC OptiBlue IOL, TECNIS OptiBlue 1-P
Johnson & Johnson Surgical Vision, Inc. · Decision date Oct 19, 2026
What did the FDA decide?
The record covers PMA P980040, supplement S186, with a 30-day notice reason listed as a process change affecting manufacturer, sterilizer, packager, or supplier. The stated change is moving microbiology testing from an external contractor to an in-house laboratory supporting product manufacturing at the AMO Puerto Rico site. The listed devices are the SENSAR 3-Piece Monofocal IOL, SENSAR 1-piece IOL, TECNIS Multi-focal 1-pc, TECNIS 1-PC OptiBlue IOL and TECNIS OptiBlue 1-P, product code HQL, applicant Johnson & Johnson Surgical Vision, Inc.
S186 is a supplement to the existing PMA identified by the database, not a new approval of the whole lens system. The source states the intended purpose of the transfer; it does not report microbiology results, testing validation data or an independent finding of safety or effectiveness. The record also does not specify which lens models the in-house laboratory serves, the tests transferred, or the contractor involved.
The decision field reads OK30, dated 2026-10-19. Beyond that label and the notice reason, the supplied fields do not describe the decision's scope or any conditions.
FDA approval order statement
the transfer of microbiology testing from an external contractor to an in-house laboratory to support product manufacturing at the AMO Puerto Rico manufacturing site
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Oct 19, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P980040/S186
- Regulatory pathway
- PMA supplement
- Product code
- HQL
- Decision code
- OK30
- Decision date
- Oct 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: intraocular lens.
- Product code
- HQL
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P980040. Subsequent supplements may change the device or its indications.
FDA decision timeline
P980040 · Original PMA
SENSAR SOFT ACRYLIC UV-LIGHT ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENS
P980040/S186 received
Application receipt date recorded by FDA.
P980040/S186 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P980040. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P980040
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | PMA approval | Feb 3, 2000 | FDA |
Explore the linked device profile
Other records with product code HQL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FINEVISION HP Trifocal IOLsP240038/S004 | Beaver-Visitec International, Inc. | PMA supplement | Oct 27, 2026 | FDA |
CT LUCIA Intraocular Lenses (IOLs)P100016/S028 | Carl Zeiss Meditec Production, LLC | PMA supplement | Oct 23, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S067 | Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
enVista Hydrophobic Acrylic Intraocular LensP910056/S066 | Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Johnson & Johnson Surgical Vision, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 31 Technology Dr., Suite 200, Irvine, CA, 92618
Sources and methodology
- Original FDA record: P980040/S186
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



